#immunogenicity

Eurofins Advinus offers custom bioanalytical testing for your biologics pipeline. Biologics are complex entities produced by living systems and are used currently in various therapies. Their analysis is more complex and challenging than traditional small molecules. Our team has wide experience in developing and validating sensitive and specific analytical/immunogenicity methods for all your biologics analysis needs. The methods are designed and optimized specifically to the requirements of your biologic product such as peptides, enzymes, monoclonal antibodies, vaccines, and gene therapy products. Click the link for more details - https://lnkd.in/d8iHcyNY

Immunogenicity is key to a successful and safe biopharmaceutical drug development program. Our team of specialists are available to help you with testing services for such products. Follow the link the connect with us, https://lnkd.in/eDKB93N

Connect them @ https://bit.ly/3e2hW97 for modifying drug pathways.

Click: http://bit.ly/3uvqFbv

For more article in Peer Reviewed Material Science Journals please click on below link https://crimsonpublishers.com/rdms/

View On WordPress

Immunogenicity assays provide a way to measure the immune responses of biologics and biosimilars. We design immune assays that provide sufficient sensitivity, detect physiological consequences, and provide predictive data about the strength and type of immune response that a drug may produce in humans. To know more about our immunogenicity assays, click https://www.immundnz.com/services/

At Immundnz, we follow an innovative method of assessing immunologic risk. We analyze drug-induced tissue damage and the immune response that may be generated from such damage. For immune risk assessment, immunogenicity and immune response testing, contact us at +44 (0)7878279127